Task: Answer the multiple-choice question.
Question: Which drug has a -27.208% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCN(CC)C(=O)CC(c1cc(OC)c(OC)c(OC)c1)c1c(O)cc(OC)cc1OC
(b) CC(=O)c1cc2c(cc1NC(=O)CCc1ccccc1)OCO2
(c) O=C(CCNS(=O)(=O)c1ccccc1)OCc1nc2ccsc2c(=O)[nH]1
Answer: c. O=C(CCNS(=O)(=O)c1ccccc1)OCc1nc2ccsc2c(=O)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCNS(=O)(=O)c1ccccc1)OCc1nc2ccsc2c(=O)[nH]1
O=C(CCNS(=O)(=O)c1ccccc1)OCc1nc2ccsc2c(=O)[nH]1
(4-oxo-3H-thieno[3,2-d]pyrimidin-2-yl)methyl 3-(benzenesulfonamido)propanoate